Matinas BioPharma Holdings, Inc.
MTNB
$0.9129
$0.0131.45%
AMEX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -96.42% | 6.12% | |||
| Gross Profit | 96.42% | -6.12% | |||
| SG&A Expenses | 11.97% | -22.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -51.81% | -7.83% | |||
| Operating Income | 51.81% | 7.83% | |||
| Income Before Tax | 80.55% | -99.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 80.36% | -97.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 80.36% | -97.26% | |||
| EBIT | 51.81% | 7.83% | |||
| EBITDA | 51.18% | 7.97% | |||
| EPS Basic | 80.36% | -95.29% | |||
| Normalized Basic EPS | 52.21% | 5.47% | |||
| EPS Diluted | 80.36% | -95.29% | |||
| Normalized Diluted EPS | 52.21% | 5.47% | |||
| Average Basic Shares Outstanding | -0.03% | 1.01% | |||
| Average Diluted Shares Outstanding | -0.03% | 1.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||